يعرض 141 - 160 نتائج من 5,745 نتيجة بحث عن '(( decrease ((therapy resistance) OR (therapeutic resistance)) ) OR ( decrease stress resistance ))', وقت الاستعلام: 0.53s تنقيح النتائج
  1. 141
  2. 142

    DataSheet1_A flavonoid-rich fraction of Euphorbia peplus attenuates hyperglycemia, insulin resistance, and oxidative stress in a type 2 diabetes rat model.docx حسب Reem S. Alruhaimi (16381122)

    منشور في 2023
    "…<p>Background: Type 2 diabetes (T2D) is a metabolic disorder characterized by insulin resistance (IR) and hyperglycemia. Plants are valuable sources of therapeutic agents for the management of T2D. …"
  3. 143

    DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf حسب Bo Li (112195)

    منشور في 2021
    "…However, the rapid emergence of resistance toward doxorubicin threatens its clinical application, thus the need for combination therapy. …"
  4. 144

    DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf حسب Bo Li (112195)

    منشور في 2023
    "…However, the rapid emergence of resistance toward doxorubicin threatens its clinical application, thus the need for combination therapy. …"
  5. 145

    DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf حسب Bo Li (112195)

    منشور في 2021
    "…However, the rapid emergence of resistance toward doxorubicin threatens its clinical application, thus the need for combination therapy. …"
  6. 146

    DataSheet_1_DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small... حسب Mingyue Liu (1519720)

    منشور في 2022
    "…In conclusion, these results demonstrated that DHW-221, as a novel P-gp inhibitor, represents a prospective therapeutic candidate to overcome MDR in Taxol-resistant NSCLC treatment.…"
  7. 147

    DataSheet_1_Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma.docx حسب Yan Zhuang (115199)

    منشور في 2023
    "…</p>Results<p>Our findings revealed a consistent decrease in the levels of complement components in the pomalidomide-resistant group. …"
  8. 148
  9. 149
  10. 150
  11. 151

    Presentation_1_Comparative Metabolomics Reveals Key Pathways Associated With the Synergistic Killing of Colistin and Sulbactam Combination Against Multidrug-Resistant Acinetobacter... حسب Mei-Ling Han (1612951)

    منشور في 2019
    "…<p>Background: Polymyxins are a last-line class of antibiotics against multidrug-resistant Acinetobacter baumannii. However, polymyxin resistance can emerge with monotherapy, highlighting the need for synergistic combination therapies. …"
  12. 152
  13. 153
  14. 154
  15. 155
  16. 156

    Image_4_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg حسب Mona M. Al-Gizawiy (17787488)

    منشور في 2024
    "…Background<p>Treatment-resistant glioblastoma (trGBM) is an aggressive brain tumor with a dismal prognosis, underscoring the need for better treatment options. …"
  17. 157

    Image_6_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg حسب Mona M. Al-Gizawiy (17787488)

    منشور في 2024
    "…Background<p>Treatment-resistant glioblastoma (trGBM) is an aggressive brain tumor with a dismal prognosis, underscoring the need for better treatment options. …"
  18. 158

    Image_1_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg حسب Mona M. Al-Gizawiy (17787488)

    منشور في 2024
    "…Background<p>Treatment-resistant glioblastoma (trGBM) is an aggressive brain tumor with a dismal prognosis, underscoring the need for better treatment options. …"
  19. 159

    Image_5_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg حسب Mona M. Al-Gizawiy (17787488)

    منشور في 2024
    "…Background<p>Treatment-resistant glioblastoma (trGBM) is an aggressive brain tumor with a dismal prognosis, underscoring the need for better treatment options. …"
  20. 160

    Image_2_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg حسب Mona M. Al-Gizawiy (17787488)

    منشور في 2024
    "…Background<p>Treatment-resistant glioblastoma (trGBM) is an aggressive brain tumor with a dismal prognosis, underscoring the need for better treatment options. …"